Taxane Pharmacogenetics
- 23 January 2006
- journal article
- Published by Taylor & Francis in Personalized Medicine
- Vol. 3 (1) , 33-43
- https://doi.org/10.2217/17410541.3.1.33
Abstract
The taxanes paclitaxel and docetaxel exert their anticancer activity by stabilizing microtubules during cell division. There is significant interindividual variability in response and toxicity between paclitaxel and docetaxel. Interpatient variability also exists for response and toxicity from each drug. Variability within genes involved in paclitaxel and/or docetaxel metabolism and transport exists. However, to date there is little evidence to suggest useful markers for the selection of individualized therapy. Epigenetic regulation of taxane pathway genes may play a large role in explaining the variability in toxicity and response.Keywords
Funding Information
- Pharmacogenetics Research Network (U01 GM63340, R21 CA113491, R21 CA102461)
This publication has 101 references indexed in Scilit:
- Association ofCYP2C8, CYP3A4, CYP3A5, andABCB1Polymorphisms with the Pharmacokinetics of PaclitaxelClinical Cancer Research, 2005
- Human CYP2C8 Is Transcriptionally Regulated by the Nuclear Receptors Constitutive Androstane Receptor, Pregnane X Receptor, Glucocorticoid Receptor, and Hepatic Nuclear Factor 4αMolecular Pharmacology, 2005
- Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein ExpressionClinical Cancer Research, 2005
- The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin DeacetylaseCancer Research, 2005
- SNP databases and pharmacogenetics: great start, but a long way to goHuman Mutation, 2002
- Genetic Analysis of the -Tubulin Gene, TUBB, in Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2001
- The Rearrangement of the Human α1-Acid Glycoprotein/Orosomucoid Gene: Evidence for Tandemly Triplicated Genes Consisting of Two AGP1 and One AGP2Biochemical and Biophysical Research Communications, 2000
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.Journal of Clinical Investigation, 1997
- Expression of cytochrome P450 CYP1B1 in breast cancerFEBS Letters, 1995